Robert L. Myers, CHIEF FINANCIAL OFFICER at Predictive Oncology Inc. (POAI), bought 16,125 shares at $0.30 ($5K) on 2022-05-20, disclosed to the SEC on 2022-05-20.
Open-market purchase of $5k POAI by CHIEF FINANCIAL OFFICER. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Clearly above the average filing.
| Filing → |
| SKLN | BUY | 2014-08-22 | $750 | — | Filing → |
| BIOR | BUY | 2013-03-11 | $500 | — | Filing → |